<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03355950</url>
  </required_header>
  <id_info>
    <org_study_id>E-16-1019</org_study_id>
    <nct_id>NCT03355950</nct_id>
  </id_info>
  <brief_title>ASA Levels in TEP and Lichtenstein Repair Patients</brief_title>
  <official_title>Comparison of Anti-sperm Antibody Levels in Inguinal Hernia Patients Who Undergo Totally Extra-peritoneal and Lichtenstein Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara Numune Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara Numune Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine and compare the possible affects of two different
      inguinal hernia repair technique (TEP and Lichtenstein) on serum ASA levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Antisperm antibody levels are thought to be indirect indicators of spermatic duct injuries.
      The investigators' ultimate goal is to draw a conclusion about the effect of the type of
      surgery on spermatic duct integrity. The investigators are going to collect serum samples
      from inguinal hernia patients before and after surgery. The investigators aim to assess the
      effect of surgery on antisperm antibody levels of patients who undergo Licthenstein and TEP
      repair. Preoperative antisperm antibody levels will serve as control levels for each patient
      group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Anti-sperm antibody levels after inguinal hernia surgery</measure>
    <time_frame>Three months for each patient</time_frame>
    <description>Samples will be collected before hernia surgery and three months after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of Anti-sperm antibody levels between inguinal hernia patients who have undergone laparoscopic totally extraperitoneal repair and Lichtenstein repair techniques</measure>
    <time_frame>2 years anticipated</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Hernia, Inguinal</condition>
  <arm_group>
    <arm_group_label>TEP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who undergo totally extraperitoneal hernia repair, TEP Repair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lichtenstein group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who undergo Lichtenstein repair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lichtenstein Repair</intervention_name>
    <description>Well defined Lichtenstein Repair for inguinal hernias</description>
    <arm_group_label>Lichtenstein group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TEP Repair</intervention_name>
    <description>Laparoscopic totally extraperitoneal repair for inguianal hernias</description>
    <arm_group_label>TEP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  to accept the terms of the randomization and all study

          -  to have unilateral inguinal hernia and set for an inguinal hernia repair

          -  to be a father

        Exclusion Criteria:

          -  to have any kind of autoimmune disorders

          -  any kind of infertility history

          -  to have a history of inguinal and/or genital surgery and/or trauma
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faruk Coskun, MD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Ankara Numune Research and Training Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Selami Ilgaz Kayılıoğlu, MD</last_name>
    <phone>+90 533 203 6595</phone>
    <email>kayilioglu@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ömer Özduman, MD</last_name>
    <phone>+90 544 253 9683</phone>
    <email>omer_ozduman@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ankara Numune Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selami Ilgaz Kayılıoğlu, MD</last_name>
      <phone>+905332036595</phone>
      <email>kayilioglu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

